Syed Hamzavi, MD
MOHS-Micrographic Surgery · Clinton Twp, MINPI 1295780989
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Insmed, Inc. at 43.3% of the total. 2025 is the largest year on record at $2,104, 5.7 times the $368 reported in 2019.
Across 106 payments — averaging $40.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insmed, Inc.$2K
- Incyte Corporation$728
- AbbVie$420
- Johnson & Johnson$215
- Novartis$190
- Kerecis Limited$142
- plus $728 from 15 others
Across 853 payments — averaging $6680.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$4.3M
- Janssen Research & Development, LLC$412K
- E.r. Squibb & Sons, L.L.C.$164K
- Nielsen Biosciences, Inc.$160K
- Amgen$119K
- Vanda Pharmaceuticals Inc.$109K
- plus $476K from 11 others
What the payments were for
- Consulting fees$68016%
- Travel & lodging$1,65839%
- Food & beverage$1,80742%
- Education$1283%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insmed, Inc. | 11 | $1,850 |
| Incyte Corporation | 4 | $728 |
| AbbVie | 25 | $420 |
| Johnson & Johnson | 11 | $215 |
| Novartis | 12 | $190 |
| Kerecis Limited | 2 | $142 |
| Pfizer | 9 | $139 |
| Genentech USA, Inc. | 7 | $107 |
| LEO Pharma Inc. | 7 | $101 |
| Amgen | 3 | $79 |
| Bristol Myers Squibb | 2 | $44 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Convatec Inc. | 1 | $39 |
| UCB, Inc. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Boehringer Ingelheim | 1 | $27 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Dermavant Sciences, Inc. | 1 | $18 |
| Strata Skin Sciences, Inc. | 2 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$4,274 in reported general payments places this provider in the 70th percentile of 30 mohs-micrographic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 25 | $200,666 |
| Dupixent PenDupilumab | 11 | $41,535 |
| Fluorouracil | 68 | $4,006 |
| Metronidazole | 26 | $3,014 |
| Clobetasol Propionate | 61 | $2,438 |
| Betamethasone Dipropionate | 38 | $1,721 |
| Ketoconazole | 67 | $1,359 |
| Ammonium Lactate | 45 | $796 |
| Triamcinolone Acetonide | 91 | $784 |
| Clindamycin Phosphate | 23 | $580 |
| Hydrocortisone | 76 | $410 |
| Imiquimod | 16 | $362 |
| Cephalexin | 70 | $324 |
| Fluocinonide | 17 | $310 |
| Clotrimazole | 21 | $224 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Clinton Twp
- Bryan SofenRoyal Oak$35K
- David OzogDetroit$22K
- Michael WhitworthWyandotte$13K
- David ByrdRochester Hills$10K
- Ryan JonesPortage$9K
- Abraham AbdulhakDearborn$8K
- Lindsay SklarWest Bloomfield$6K
- Luke NicholasRockford$4K
- Aaron CetnerWest Bloomfield$3K
- Ayad AbrouRochester Hills$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.